Mitoapocynin Treatment Protects Against Neuroinflammation and Dopaminergic Neurodegeneration in a Preclinical Animal Model of Parkinson’s Disease

Mitochondrial dysfunction, oxidative stress and neuroinflammation have been implicated as key mediators contributing to the progressive degeneration of dopaminergic neurons in Parkinson’s disease (PD). Currently, we lack a pharmacological agent that can intervene in all key pathological mechanisms,...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Neuroimmune Pharmacol
Huvudupphovsmän: Ghosh, Anamitra, Langley, Monica R, Harischandra, Dilshan, Neal, Matthew L, Jin, Huajun, Anantharam, Vellareddy, Joseph, Joy, Brenza, Timothy, Narasimhan, Balaji, Kanthasamy, Arthi, Kalyanaraman, Balaraman, Kanthasamy, Anumantha G.
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2016
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4995106/
https://ncbi.nlm.nih.gov/pubmed/26838361
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11481-016-9650-4
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk